Affiliation: SmithKline Beecham Pharmaceuticals
- Warfarin pharmacodynamics unaffected by cilomilastJ Kelly
GlaxoSmithKline, New Frontiers Science Park, Third Ave, Harlow, CM19 5AW Essex, UK
Ann Pharmacother 35:1535-9. 2001..To demonstrate a lack of effect of steady-state concentrations of cilomilast, a new oral phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease, on warfarin-induced anticoagulation...
- Cilomilast (Ariflo) does not potentiate the cardiovascular effects of inhaled salbutamolR D Murdoch
Clinical Pharmacology, GlaxoSmithKline, Harlow, UK
Pulm Pharmacol Ther 15:521-7. 2002..Both agents were well tolerated. In conclusion, the pharmacodynamic effects associated with salbutamol inhalation were unaffected by co-administration of cilomilast...